HEATHER WILLISON: Open Payments
NPI 1376030304 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 79 payments from 13 companies in 2025. Trend: 2023 $1,779 · 2024 $2,291 · 2025 $1,607
Food & beverage: $1,573Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $437 |
| CSL Behring | 11 | $257 |
| GENZYME CORPORATION | 6 | $167 |
| GlaxoSmithKline, LLC. | 24 | $155 |
| Amgen Inc. | 8 | $150 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| BioCryst US Sales Co., LLC | 3 | $59 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $58 |
| Genentech USA, Inc. | 2 | $35 |
Products named: TEZSPIRE, DUPIXENT, Andembry, NUCALA, BREZTRI, Haegarda, TAKHZYRO, ORLADEYO.
Industry payments across IN — which companies pay providers there.
